Amniotic fluid embolism (AFE) is a rare obstetric emergency in which amniotic fluid, fetal cells, hair, or other debris enters the mother's blood stream via the placental bed of the uterus and trigger an allergic reaction. This reaction then results in cardiorespiratory (heart and lung) collapse and coagulopathy. Amniotic fluid embolism (AFE) is a pregnancy complication that causes life-threatening conditions, such as heart failure. It can affect you, your baby, or both of you.
Amniotic fluid results from entering the maternal circulation via the uterine veins, which then has either a direct effect on the lungs, or triggers an immune response in the mother.There is no particular treatment for amniotic liquid embolism, and introductory crisis administration is the same concerning some other reason for sudden maternal breakdown - with cardiovascular and respiratory revival and adjustment of the coagulopathy. Be that as it may, more up to date research with creature models recommend that critical embolism of any material is trailed by platelet degranulation, pneumonic hypertension because of serotonin and thromboxane, and systemic hypotension because of vagal incitement.
As previously reported , information on incident cases (fatal and non-fatal) for Canada was based on all hospital deliveries as documented in the Discharge Abstract Database of the Canadian Institute for Health Information from 1991 to 2002, which records all deliveries in Canada with the exception of those in Quebec, Manitoba and Nova Scotia (thus approximately 70% of deliveries). All medical diagnoses were coded using the International Classification of Diseases (ICD-9 up to 2000, and a combination of ICD-9 and ICD-10 from 2001-2002), while procedures were coded using the Canadian Classification of Diagnostic, Therapeutic and Surgical Procedures (CCP) for 1991-2001 and the Canadian Classification of Interventions (CCI) for 2001-2.